Marcel Behr appointed interim director 不良研究所 Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency of Canada
听was appointed interim director of the 不良研究所 Interdisciplinary Initiative in Infection and Immunity (MI4), Faculty of Medicine and Health Sciences, 不良研究所, in November 2021. The co-director (Infection) of MI4 prior to this appointment, he will continue to work with Dr. Marie Hudson, also a co-director (Immunity) since 2019.
Read more about听听and MI4 on the 不良研究所 website.
听
听
Ben Geboe awarded the 2021-2022 Dr. Margaret Becklake Fellowship for research with urban Indigenous populations听
The RI-MUHC postdoc is working on a culturally safe framework for TB prevention and care for Indigenous populations in Montreal
Read article
Regular screening for tuberculosis in Inuit communities is cost-effective听
A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks
Dr. Kevin Schwartzman, Senior Scientist in the Translational Research in Respiratory Diseases Program at the RI-MUHC and first author Aashna Uppal, MScPH.
Read article听
Tuberculosis Trials Consortium Clinical (2020-2030)
听 听 听 听 听 听 听 听 听 听 听 听 听
RI-MUHC is being awarded听the听Tuberculosis Trials Consortium Clinical from听the Centers for Disease Control and Preventions (CDC) in the amount of $USD 13.5 million.
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis . Emphasis will be given to studies of latent TB infection in low- and medium- TB incidence settings, inclusive of but not limited to the United States and Canada, as well as studies of active TB disease both domestically and internationally.
More information on the TBTC can be found听.
TB Centre Members Awarded听4-year CIHR Project Grant
Dr. Simon Grandjean Lapierre (PI), Dr. Marcel Behr (Co-I) and Dr. Kevin Schwartzman (Co-I) have been awarded a 4-year project grant from the Canadian Institutes of Health Research for their project titled 鈥淭uberculosis Whole Genome Sequencing for Disease Control in Madagascar - A Cluster Randomized Controlled Trial to Evaluate Different Community-Level Strategies to Reduce the Burden of Disease鈥�.
Some of our Award-winning Investigators
-
Dr Dick Menzies听 听 听听
听Dr. Dick Menzies, Director of the Respiratory Epidemiology Unit at 不良研究所 and 不良研究所鈥檚 World Health Organization Collaborating Centre in TB Research, has been named recipient of the 2019 CIHR-ICRH/CTS Distinguished Lecturer Award (DLA) in Respiratory Sciences.
Each year, the DLA Series honours outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) research community who have contributed significantly to the advancement of science in their field听both in Canada and internationally.听
-
Dr Marcel Behr听 听听听
听Dr. Marcel Behr has been elected to Fellowship in the American Academy of Microbiology. The Academy recognizes excellence, originality, and leadership in the microbiological sciences.听
He has also been elected as听Tier 1 Canada Research Chair for听Mycobacterial Genomics.
Tier 1 Canada Research Chairs (CRC) are for outstanding researchers acknowledged by their peers as world leaders in their fields. A Chair is tenable for seven years and renewable once.
-
Dr Madhukar Pai听 听 听听
听 听 听 听 听 听听Dr. Madhukar Pai serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the听Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance. He is on the editorial boards of听Lancet Infectious Diseases,听PLoS Medicine,听eLife,听PLoS ONE,听 International Journal of TB and Lung Disease, among others.听听
He is a member of the Royal Society of Canada, and an elected Fellow of the Canadian Academy of Health Sciences.听
